Loading stock data...

Johnson Pharmacare Ltd.

BSE: JOHNPHARMA

BSE
0.76 -0.01 (-1.30%)

Prev Close

0.77

Open Price

0.77

Volume

888,112

Today Low / High

0.75 / 0.77

52 WK Low / High

0.75 / 1.2

Range

1 - 1

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 0.76, reflecting a change of -0.01 (-1.2987%). The expected target range on the BSE is 1 - 1. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

29 Sep 0.77 0.00%
26 Sep 0.77 0.00%
25 Sep 0.77 -1.30%
24 Sep 0.78 -1.28%
23 Sep 0.77 -1.30%
22 Sep 0.78 -1.28%
19 Sep 0.79 -1.27%
18 Sep 0.77 1.30%
17 Sep 0.79 -1.27%
16 Sep 0.77 0.00%
15 Sep 0.77 1.30%
12 Sep 0.78 -1.28%
11 Sep 0.79 -1.27%
10 Sep 0.79 0.00%
09 Sep 0.79 -2.53%
08 Sep 0.79 -1.27%
05 Sep 0.78 1.28%
04 Sep 0.82 -3.66%
03 Sep 0.80 0.00%

Johnson Pharmacare Ltd. Graph

Johnson Pharmacare Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Johnson Pharmacare Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 0.76, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 0.76 0.77 0.69 - 0.84
0.78 0.62 - 0.93
0.78 0.55 - 1.02
Bearish Scenario 0.76 0.75 0.68 - 0.83
0.74 0.60 - 0.89
0.74 0.52 - 0.96

Overview of Johnson Pharmacare Ltd.

ISIN

INE560F01022

Industry

Financial - Conglomerates

Vol.Avg

1,045,929

Market Cap

423,500,000

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

0.78

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for JOHNPHARMA

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr -0.08 Cr -0.58 Cr -0.01 -0.58 Cr 0.0000
2024-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr -0.20 Cr -0.20 Cr 0.00 -0.20 Cr 0.0000
2023-03-31 2.53 Cr 2.09 Cr 0.43 Cr 0.1715 0.00 Cr 0.01 Cr 0.22 Cr -1.29 Cr -0.02 -1.33 Cr -0.5111
2022-03-31 3.26 Cr 2.79 Cr 0.48 Cr 0.1457 0.00 Cr 0.02 Cr 0.13 Cr 0.10 Cr 0.00 0.13 Cr 0.0296
2021-03-31 0.76 Cr 0.67 Cr 0.09 Cr 0.1132 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 0.00 Cr 0.0015

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.01 Cr 57.93 Cr 1.76 Cr 56.1691 Cr 0.61 Cr 0.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 42.29 Cr 1.1513 Cr
2024-03-31 0.00 Cr 59.83 Cr 3.08 Cr 56.7530 Cr 1.95 Cr 1.95 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 45.56 Cr 1.1264 Cr
2023-03-31 0.00 Cr 59.83 Cr 2.88 Cr 56.9492 Cr 1.91 Cr 1.90 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 59.83 Cr 0.9756 Cr
2022-03-31 0.04 Cr 59.98 Cr 1.74 Cr 58.2406 Cr 0.61 Cr 0.56 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 58.89 Cr 1.1346 Cr
2021-03-31 0.23 Cr 59.48 Cr 1.34 Cr 58.1440 Cr 0.69 Cr 0.46 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 53.88 Cr 0.6514 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 1.9089 Cr 3.2668 Cr 1.3450 Cr 0.0000 Cr 0.0130 Cr 0.0144 Cr 0.0000 Cr -0.5838 Cr 1.3450 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 -0.0454 Cr 0.0000 Cr 0.0450 Cr -0.0454 Cr -0.0004 Cr 0.0014 Cr 0.0000 Cr -0.1962 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 -11.5847 Cr 10.2459 Cr 1.3000 Cr -11.5847 Cr -0.0388 Cr 0.0018 Cr 0.0000 Cr -1.2914 Cr 1.3000 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 4.8966 Cr -5.0057 Cr -0.0830 Cr 4.8966 Cr -0.1921 Cr 0.0406 Cr 0.0000 Cr 0.0967 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 -0.1084 Cr 0.0000 Cr 0.0622 Cr -0.1084 Cr -0.0462 Cr 0.2327 Cr 0.0000 Cr 0.0012 Cr 0.0622 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.05 Cr -0.05 Cr 0.00 -0.05 Cr 0.0000
2025-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.01 Cr -0.51 Cr -0.01 -0.51 Cr 0.0000
2024-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.03 Cr -0.03 Cr 0.00 -0.03 Cr 0.0000
2024-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr 0.00 0.00 Cr 0.0000
2024-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.04 Cr -0.04 Cr 0.00 -0.04 Cr 0.0000

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.01 Cr 0.01 Cr 0.01 Cr 14.27 Cr 0.00 Cr 15.63 Cr 0.00 Cr 57.93 Cr 1.76 Cr
2024-09-30 0.00 Cr 0.00 Cr 0.00 Cr 14.27 Cr 0.00 Cr 14.27 Cr 0.00 Cr 59.83 Cr 3.12 Cr
2024-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 59.83 Cr 3.08 Cr
2023-09-30 0.00 Cr 0.00 Cr 0.00 Cr 14.27 Cr 0.00 Cr 14.27 Cr 0.00 Cr 59.83 Cr 3.07 Cr
2023-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 59.83 Cr 2.88 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-06-30 -0.19 Cr -0.19 Cr 0.00 Cr 0.00 Cr -0.19 Cr -0.19 Cr 0.00 Cr 0.00 Cr -0.19 Cr
2023-03-31 -0.08 Cr -0.08 Cr 0.00 Cr 0.00 Cr -0.08 Cr 0.00 Cr 0.09 Cr 0.00 Cr -0.08 Cr
2022-12-31 -1.56 Cr -1.56 Cr 0.00 Cr 0.00 Cr -1.56 Cr -1.56 Cr 0.00 Cr 0.00 Cr -1.56 Cr

Splits History

Date Label Split Ratio
2022-04-07 April 07, 22 11:10
2022-01-05 January 05, 22 10:1

Similar Stocks: Financial - Conglomerates

Company Name Symbol Price Market Cap Volume
Bajaj Finserv Ltd. BAJAJFINSV ₹2,006.40 ₹3,202,709,633,693.00 ₹924,084.00
Aditya Birla Capital Limited ABCAPITAL ₹292.35 ₹763,746,834,000.00 ₹4,664,742.00
IndiGrid Infrastructure Trust INDIGRID-IV ₹165.01 ₹137,710,415,580.00 ₹405,161.00

Key Executives

Chairman, Compliance Officer & Chief Financial Officer
Mr. Ramanlal Nagjibhai Trivedi

Gender: male

Year Born: 1950

FAQs about Johnson Pharmacare Ltd.

Who is the CEO of the company?

The CEO is Ramanlal Nagjibhai Trivedi.

What is the current market price of the stock?

The current price is ₹0.77.

What is the 52-week price range?

The range is ₹0.75-1.2.

What is the market capitalization of the company?

The market capitalization is ₹42.35 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -70.90.

Which sector does the company belong to?

The company operates in the Financial Services sector.

What does the company do?

Overview of Johnson Pharmacare Ltd. (ISIN: INE560F01022) is a leading Financial - Conglomerates in India. With a market capitalization of ₹42.35 crores and an average daily volume of 1,045,929 shares, it operates in the Financial - Conglomerates. The company last declared a dividend of ₹0.